-
Research released at the International Conference on Alzheimer's Disease suggests that adhering to a Mediterranean diet may decrease risk of dementia. It is also linked to benefits for people with high blood pressure or pre-hypertension. The study used a survey which included a cognitive assessment and food frequency questions in ...
-
The development of essential dementia diagnostic tools could be achieved through the combined observation of biomarkers with other measures such as brain volume, according to research studies. Previous research has typically concentrated on one area. The study led by Dr Susan Landau involved measurement of brain volume by scans, combined ...
-
Health Secretary Andy Burnham set out three new models of funding adult social care in England yesterday. Publishing the Green Paper Shaping the Future of Care Together the government pledged a radical overhaul of the current charging system and welcomed debate on which model was fit for the future. The ...
-
Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, today announced further evidence for genetic interactions impacting the efficacy of the ketogenic compound AC-1202 (Axona(TM)) in Alzheimer's disease....
-
A group of Utah State University researchers and colleagues at Johns Hopkins University, Duke University and Boston University have demonstrated that the rate of clinical progression of dementia may be slowed by a close relationship with one's caregiver....
-
Memantine improves functional communication skills in patients with moderate to severe Alzheimer's disease (AD), noticeable by caregivers. These are the study results discussed at the International Conference on Alzheimer's Disease (ICAD). The data of two recent clinical trials support that AXURA®/AKATINOL® - an uncompetitive NMDA receptor antagonist - effects language ...
-
Results from two large studies using DHA, an omega 3 fatty acid, were reported at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) in Vienna.One of the trials was conducted by the Alzheimer's Disease Cooperative Study (ADCS) supported by the U.S. National Institute on Aging (NIA), and ...
-
The number of people with Alzheimer's and dementia - both new cases and total numbers with the disease - continues to rise among the very oldest segments of the population in contradiction of the conventional wisdom, according to research reported at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease ...
-
Elan Corporation, plc (NYSE: ELN) and Transition Therapeutics Inc. (TSX: TTH, NASDAQ: TTHI) today presented Phase 1 data demonstrating that treatment with ELND005 (scyllo-inositol formerly known as AZD-103), achieves desired concentrations in human brain tissue and cerebrospinal fluid when given orally....
-
A glass of wine here, a nightcap there - new research out of Wake Forest University School of Medicine suggests that moderate alcohol intake offers long-term cognitive protection and reduces the risk of dementia in older adults. The study is being presented at the Alzheimer's Association 2009 International Conference on ...
-
Bayer Schering Pharma AG, Germany, has presented positive data on a global Phase II study with the novel positron emission tomography (PET) tracer florbetaben (BAY 94-9172) at the International Conference on Alzheimer's Disease (ICAD) in Vienna, Austria. This study showed that patients with a clinical diagnosis of Alzheimer´s disease could ...
-
Researchers in the US found that the destructive cellular pathways that occur following traumatic brain injury are the same as those activated in Alzheimer's Disease, suggesting that both conditions could be treated with new drugs that target these pathways. They said the findings "cement" the relationship beween traumatic brain injury ...
-
Partnering with local physicians, working with local clinics, and conducting educational seminars and health fairs were found to be the most effective tools in recruiting people for Alzheimer's clinical studies, according to new research reported at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) in Vienna....
-
A doctor's positive attitude to Alzheimer's diagnosis and their trusting, personal relationships with local dementia support service providers are powerful enablers for early diagnosis of Alzheimer's, according to new research reported at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) in Vienna....
-
Researchers at Mount Sinai School of Medicine have found that a compound called NIC5-15, might be a safe and effective treatment to stabilize cognitive performance in patients with mild to moderate Alzheimer's disease. The two investigators, Giulio Maria Pasinetti, M.D., Ph.D. , and Hillel Grossman, M.D., presented Phase IIA preliminary ...
-
The destructive cellular pathways activated in Alzheimer's disease are also triggered following traumatic brain injury, say researchers from Georgetown University Medical Center (GUMC). They say this finding suggests that novel therapy might successfully target both conditions....
-
Results from two large studies using DHA, an omega 3 fatty acid, were reported at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) in Vienna. One of the trials was conducted by the Alzheimer's Disease Cooperative Study (ADCS) supported by the National Institute on Aging (NIA), and ...
-
A new Mayo Clinic study may help physicians differentially diagnose three common neurodegenerative disorders in the future. The study was presented at the Alzheimer's Association International Conference on Alzheimer's Disease on July 11 in Vienna....
-
Promoting new discoveries in brain research and mental disorders Mental disorders are a global problem and represent one of the biggest challenges for health care systems. In the world, there are some 500 million people suffering from mental disorders, and in the European Union, mental disorders range as one of ...
-
A group of chemicals found in many fruits and vegetables, as well as tea, cocoa and red wine, could protect the brain from Alzheimer's disease, a dementia expert will tell scientists at a conference today (Friday)....
